HIV-associated monoclonal gammopathy: A retrospective analysis of 25 patients

Clinical Infectious Diseases

Volumn 43, Issue 9, 2006, Pages 1198-1205

  Amara, Sashi ^a   Dezube, Bruce J ^g   Cooley, Timothy P ^d,e   Pantanowitz, Liron ^f   Aboulafia, David M ^a,b,c  

^a VIRGINIA MASON MEDICAL CENTER   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^f TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g Virginia Mason Medical Center ^*

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ALPHA INTERFERON; ANTIRETROVIRUS AGENT; ATAZANAVIR; BENCE JONES PROTEIN; BETA 2 MICROGLOBULIN; DELAVIRDINE; DIDANOSINE; EFAVIRENZ; EMTRICITABINE; ENFUVIRTIDE; HEMOGLOBIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN M; INDINAVIR; LAMIVUDINE; LOPINAVIR; M PROTEIN; MONOCLONAL ANTIBODY; NELFINAVIR; NEVIRAPINE; RIBAVIRIN; RITONAVIR; SAQUINAVIR; TENOFOVIR; UNINDEXED DRUG; ZIDOVUDINE;

ADULT; AGED; ANEMIA; BONE MARROW BIOPSY; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HODGKIN DISEASE; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERCALCEMIA; IMMUNOELECTROPHORESIS; IMMUNOGLOBULIN BLOOD LEVEL; KAPOSI SARCOMA; KIDNEY FAILURE; MALE; MALIGNANT NEOPLASTIC DISEASE; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; PLASMA CELL DYSCRASIA; PLASMACYTOMA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; SUPERINFECTION; VIREMIA; VIRUS INFECTION; VIRUS LOAD; VISCOSITY; ARTICLE; B CELL LYMPHOMA; MIDDLE AGED; PARAPROTEINEMIA;

ADULT; AGED; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HEPATITIS B; HEPATITIS C; HIV INFECTIONS; HUMANS; LYMPHOMA, AIDS-RELATED; MALE; MIDDLE AGED; PARAPROTEINEMIAS; RETROSPECTIVE STUDIES; SARCOMA, KAPOSI;

EID: 33750123206     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/508351     Document Type: Review

References (24)

1. International Myeloma Working Group. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol 2003; 121:747-57.
2. Kyle RA, Therneau TM, Rajkumar SV, et al. A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med 2002; 346:564-9.
3. Pantanowitz L, Beckwith BA, Horowitz GL, Dezube BJ. HIV-associated gammopathy in the HAART era: association with HIV viremia [abstract A78]. In: Program and abstracts of the 8th International Conference on Malignancies in AIDS and Other Immunodeficiencies (ICMAOI): Basic, Epidemiologic and Clinical Research (Bethesda, MD). Bethesda, MD: National Cancer Institute, 2004:101.
4. Dezube BJ, Aboulafia DM, Pantanowitz L. Plasma cell disorders in HIV-infected patients: from benign gammopathy to multiple myeloma. AIDS Read 2004; 14:372-9.
5. Lefrere JJ, Debbia M, Lambin P. Prospective follow-up of monoclonal gammopathies in HIV-infected individuals. Br J Haematol 1993; 84:151-5.
6. Briault S, Courtois-Capella M, Duarte F, Aucouturier P, Preud'Homme JL. Isotypy of serum monoclonal immunoglobulins in human immunodeficiency virus-infected adults. Clin Exp Immunol 1988; 74:182-4.
7. Fiorino AS, Atac B. Paraproteinemia, plasmacytoma, myeloma and HIV infection. Leukemia 1997; 11:2150-6.
8. Lefrere JJ, Fine JM, Marneux M, Lambin P, Salmon C. Follow-up of monoclonal gammopathies in asymptomatic HIV-infected subjects. Clin Chem 1989; 35:338-9.
9. Sala PG, Mazzolini S, Tonutti E, Bramezza M. Monoclonal immunoglobulins in HTLV III-positive sera. Clin Chem 1986; 32:574.
10. Konrad RJ, Kricka LJ, Goodman DB, Goldman I, Silberstein LE. Brief report: myeloma-associated paraprotein directed against the HIV-1 p24 antigen in an HIV-1-seropositive patient. N Engl J Med 1993; 328:1817-9.
11. Ng VL, Hwang KM, Reyes GR, et al. High titer anti-HIV antibody reactivity associated with a paraprotein spike in a homosexual male with AIDS related complex. Blood 1988; 71:1397-401.
12. Klein B, Zhang XG, Lu ZY, Bataille R. Interleukin-6 in human multiple myeloma. Blood 1995; 85:863-72.
13. Carraway H, Ambinder RF. Plasma cell dyscrasia, Hodgkin lymphoma, HIV, and Kaposi sarcoma-associated herpesvirus. Curr Opin Oncol 2002; 14:543-5.
14. Azzi A, Fanci R, De Santis R, Ciappi S, Paci C. Human herpesvirus 8 DNA sequences are present in bone marrow from HIV-negative patients with lymphoproliferative disorders and from healthy donors. Br J Haematol 2001; 113:188-90.
15. Piechowiak H, Hehlmann R, Abb J, et al. Changing biclonal gammopathy due to different lymphocyte clones in acquired immunodeficiency syndrome with Kaposi's sarcoma. Klin Wochenschr 1985; 63:1083-6.
16. Aboulafia DM. Thalidomide-based treatment for HIV-associated multiple myeloma: a case report. AIDS Read 2003; 13:383-9.
17. Ng VL, Chen KH, Hwang KM, Khayam-Bashi H, McGrath MS. The clinical significance of human immunodeficiency virus type 1-associated paraproteins. Blood 1989; 74:2471-5.
18. Hamazaki K, Baba M, Hasegawa H, et al. Chronic hepatitis C associated with monoclonal gammopathy of undetermined significance. J Gastroenterol Hepatol 2003; 18:459-60.
19. Sungkanuparph S, Overton ET, Seyfried W, Groger RK, Fraser VJ, Powderly WG. Intermittent episodes of detectable HIV viremia in patients receiving nonnucleoside reverse-transcriptase inhibitor-based or protease inhibitor-based highly active antiretroviral therapy regimens are equivalent in incidence and prognosis. Clin Infect Dis 2005; 41:1326-32.
20. Cauda R, Lucia MB, Marasca G, et al. Beneficial effect of highly active antiretroviral therapy (HAART) in reducing both HIV viral load and monoclonal gammopathy. Eur J Haematol 1999; 63:134-5.
21. Goedert JJ, Cote TR, Virgo P, et al. Spectrum of AIDS-associated malignant disorders. Lancet 1998; 351:1833-9.
22. Clarke CA, Glaser SL. Population-based surveillance of HIV-associated cancers: utility of cancer registry data. J Acquir Immune Defic Syndr 2004; 36:1083-91.
23. Rajkumar SV, Kyle RA, Therneau TM, et al. Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance. Blood 2005; 106:812-7.
24. Johnson CC, Wilcosky T, Kvale P, et al. Cancer incidence among HIV infected cohort. Am J Epidemiol 1997; 146:470-5.